{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T17:27:22Z","timestamp":1785864442334,"version":"3.56.0"},"reference-count":17,"publisher":"BMJ","issue":"11","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2021,10,7]]},"published-print":{"date-parts":[[2021,11]]},"abstract":"<jats:p>Ruxolitinib (RUX) is a kinase inhibitor used in the treatment of various medical conditions and its mechanism of action involves suppression of the immune system. While beneficial in treatment of polycythemia vera, myelofibrosis and other indications, it can also increase a patient\u2019s susceptibility to various infections, including bacterial, viral and fungal. We present a case of a patient being treated with RUX who presented with a disseminated fungal infection. This case emphasises the need for vigilance of endemic fungal infections in individuals who are on RUX therapy.<\/jats:p>","DOI":"10.1136\/bcr-2021-243694","type":"journal-article","created":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T13:10:39Z","timestamp":1635772239000},"page":"e243694","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Disseminated blastomycosis in a patient with polycythemia vera on ruxolitinib"],"prefix":"10.1136","volume":"14","author":[{"given":"Kristen","family":"Zeitler","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Tampa General Hospital, Tampa, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ripal","family":"Jariwala","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of California San Francisco, San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Alrabaa","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and International Medicine, Department of Internal Medicine, University of South Florida, Tampa, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chakrapol","family":"Sriaroon","sequence":"additional","affiliation":[{"name":"Pulmonary\/Critical Care, University of South Florida, Tampa, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2021,11,1]]},"reference":[{"key":"2025082803361410000_14.11.e243694.1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2018834044"},{"key":"2025082803361410000_14.11.e243694.2","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/ajh.24976","article-title":"Ruxolitinib-associated infections: a systematic review and meta-analysis","volume":"93","author":"Lussana","year":"2018","journal-title":"Am J Hematol"},{"key":"2025082803361410000_14.11.e243694.3","unstructured":"Jakafi (ruxolitinib) [package insert]. Wilmington, DE: Incyte Corporation; 2020."},{"key":"2025082803361410000_14.11.e243694.4","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-10-531103"},{"key":"2025082803361410000_14.11.e243694.5","unstructured":"Spaner DE , Wang G , Mccaw L . Haematologica 2016, letter to the editor.."},{"key":"2025082803361410000_14.11.e243694.6","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12113132","article-title":"Ruxolitinib-Associated infections in polycythemia vera: review of the literature, clinical significance, and recommendations","volume":"12","author":"Sadjadian","year":"2020","journal-title":"Cancers"},{"key":"2025082803361410000_14.11.e243694.7","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaa167","article-title":"Coccidioidomycosis in patients treated with ruxolitinib","volume":"7","author":"Kusne","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"2025082803361410000_14.11.e243694.8","unstructured":"Centers for Disease Control and Prevention . Available: https:\/\/www.cdc.gov\/fungal\/pdf\/more-information-about-fungal-maps-508.pdf [Accessed 20 Sep 2021]."},{"key":"2025082803361410000_14.11.e243694.9","doi-asserted-by":"publisher","DOI":"10.1080\/23744235.2017.1390248"},{"key":"2025082803361410000_14.11.e243694.10","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2147\/TCRM.S121683","article-title":"Ruxolitinib in myelofibrosis: to be or not to be an immune disruptor","volume":"13","author":"Manduzio","year":"2017","journal-title":"Ther Clin Risk Manag"},{"key":"2025082803361410000_14.11.e243694.11","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s12281-019-00350-w","article-title":"Small-Molecule protein kinases inhibitors and the risk of fungal infections","volume":"13","author":"Bechman","year":"2019","journal-title":"Curr Fungal Infect Rep"},{"key":"2025082803361410000_14.11.e243694.12","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s12281-019-00343-9","article-title":"Fungal infections with ibrutinib and other small-molecule kinase inhibitors","volume":"13","author":"Zarakas","year":"2019","journal-title":"Curr Fungal Infect Rep"},{"key":"2025082803361410000_14.11.e243694.13","unstructured":"Centers for Disease Control and Prevention . Blastomycosis. Available: https:\/\/wwwn.cdc.gov\/nndss\/conditions\/blastomycosis\/case-definition\/2020\/ [Accessed 27 Feb 2021]."},{"key":"2025082803361410000_14.11.e243694.14","doi-asserted-by":"publisher","DOI":"10.1086\/513647"},{"key":"2025082803361410000_14.11.e243694.15","article-title":"Cutaneous, intranasal blastomycosis infection in two patients from southern West Virginia: diagnostic dilemma","volume":"10","author":"Kuzel","year":"2018","journal-title":"Cureus"},{"key":"2025082803361410000_14.11.e243694.16","doi-asserted-by":"publisher","DOI":"10.1086\/648724"},{"key":"2025082803361410000_14.11.e243694.17","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-019-0388-x"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2021-243694","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T10:36:27Z","timestamp":1756377387000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2021-243694"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":17,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,11,1]]},"published-print":{"date-parts":[[2021,11]]}},"alternative-id":["10.1136\/bcr-2021-243694"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2021-243694","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11]]}}}